| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/27/2013 | CN102153541B Bispyridyl benzimidazole compounds and synthesis method thereof |
| 03/27/2013 | CN102036955B Hydroxamate-based inhibitors of deacetylases b |
| 03/27/2013 | CN101903347B Piperidinyl and piperazinyl modulators of gamma-secretase |
| 03/27/2013 | CN101903340B Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 03/27/2013 | CN101679287B Nicotinic acetylcholine receptor modulators |
| 03/27/2013 | CN101627028B Substituted diazepan compounds as orexin receptor antagonists |
| 03/27/2013 | CN101558040B Dihydropyridine derivatives useful as protein kinase inhibitors |
| 03/27/2013 | CN101460482B Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 03/27/2013 | CN101454311B Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 03/27/2013 | CN101448821B Carboxamide spirolactam cgrp receptor antagonists |
| 03/27/2013 | CN101442909B Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 03/27/2013 | CN101423513B Amine pyrimidine derivates, and production method thereof, and medicament composition and use |
| 03/27/2013 | CN101321748B 异喹啉衍生物 Isoquinoline derivatives |
| 03/27/2013 | CN101287721B 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use |
| 03/27/2013 | CN101273029B Bicyclic bisamide derivatives and use thereof as insecticides |
| 03/27/2013 | CN101160317B Process for preparing macrocyclic compounds |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
| 03/27/2013 | CN101128427B Heterocyclic compounds as ccr2b antagonists |
| 03/26/2013 | US8404856 Non-nucleoside reverse transcriptase inhibitors |
| 03/26/2013 | US8404854 Barium salt of benzimidazole derivative |
| 03/26/2013 | US8404853 Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404851 1,3,5-trisubstituted triazole derivative |
| 03/26/2013 | US8404837 Quinoline derivatives as P13 kinase inhibitors |
| 03/26/2013 | US8404765 Sterically hindered amines and use thereof as polymer stabilizers |
| 03/26/2013 | US8404718 Combinations of pyrazole kinase inhibitors |
| 03/26/2013 | US8404708 Dual NK1/NK3 receptor antagonists |
| 03/26/2013 | US8404698 Quinazoline derivatives and therapeutic use thereof |
| 03/26/2013 | US8404696 Quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| 03/26/2013 | US8404693 Substituted piperidine compounds and methods of their use |
| 03/26/2013 | US8404690 Piperazine-2-carboxamide derivatives |
| 03/26/2013 | US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/26/2013 | US8404683 Inhibitors of the interaction between MDM2 and P53 |
| 03/26/2013 | US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| 03/26/2013 | US8404679 Pyrrolidine derivatives as NK2 receptor antagonists |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | CA2712619C Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof |
| 03/26/2013 | CA2583845C 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 03/21/2013 | WO2013040535A2 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same |
| 03/21/2013 | WO2013040059A1 Novel imidazole amines as modulators of kinase activity |
| 03/21/2013 | WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/21/2013 | WO2013039988A1 Azaindazoles |
| 03/21/2013 | WO2013039851A1 Optical agents for imaging and visualization of matrix metalloproteinase enzymes |
| 03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
| 03/21/2013 | WO2013039057A1 Pyrrolidine-3-ylacetic acid derivative |
| 03/21/2013 | WO2013038944A1 Light-emitting element material and light-emitting element |
| 03/21/2013 | WO2013038378A1 Pyridine amide derivatives |
| 03/21/2013 | WO2013037896A1 Disubstituted 5-fluoro-pyrimidines |
| 03/21/2013 | WO2013037812A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
| 03/21/2013 | WO2013037779A1 New dihydroquinoline-2-one derivatives |
| 03/21/2013 | WO2013037755A1 Plant growth regulating compounds |
| 03/21/2013 | WO2013037721A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 03/21/2013 | WO2013037704A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 03/21/2013 | WO2013037703A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 03/21/2013 | WO2013037293A1 N-indol-1-amide compounds and application as anticancer medicament |
| 03/21/2013 | WO2013037291A1 Process for the preparation of n-substituted pyrazole compounds |
| 03/21/2013 | WO2012154009A3 Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases |
| 03/21/2013 | WO2012085648A9 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof |
| 03/21/2013 | US20130072679 Dihydroquinoline-2-one derivatives |
| 03/21/2013 | US20130072524 Compositions And Methods Of Synthesis Of Pyridinolypiperidine 5-HT1F Agonists |
| 03/21/2013 | US20130072523 Analogues for the treatment or prevention of flavivirus infections |
| 03/21/2013 | US20130072518 BICYCLIC COMPOUNDS AS alpha4 beta2 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| 03/21/2013 | US20130072511 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 03/21/2013 | US20130072510 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 03/21/2013 | US20130072499 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
| 03/21/2013 | US20130072496 Formulations containing pyridazine compounds |
| 03/21/2013 | US20130072489 Triazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072487 Prolyl hydroxylase inhibitors |
| 03/21/2013 | US20130072486 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
| 03/21/2013 | US20130072479 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 03/21/2013 | US20130072469 Heteroaryl compounds and uses thereof |
| 03/21/2013 | US20130072468 Substituted piperazines as cb1 antagonists |
| 03/21/2013 | US20130072461 Triazole compounds that modulate hsp90 activity |
| 03/21/2013 | US20130072457 Pyrazolyl quinazoline kinase inhibitors |
| 03/21/2013 | DE19882401B3 Blockoligomere, enthaltend 1-Kohlenwasserstoffoxy-2,2,6,6-tetramethyl-4-piperidyl-Gruppen als Stabilisatoren für organische Materialien Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 03/21/2013 | CA2848806A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles |
| 03/21/2013 | CA2848616A1 Disubstituted 5-fluoro-pyrimidines |
| 03/21/2013 | CA2846785A1 New dihydroquinoline-2-one derivatives |
| 03/21/2013 | CA2846779A1 Plant growth regulating compounds |
| 03/21/2013 | CA2844865A1 3-pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents |
| 03/21/2013 | CA2844835A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 03/21/2013 | CA2844834A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides |
| 03/21/2013 | CA2844830A1 Novel imidazole amines as modulators of kinase activity |
| 03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/21/2013 | CA2844617A1 Pyrrolidine-3-ylacetic acid derivative |
| 03/20/2013 | EP2570411A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 03/20/2013 | EP2570410A1 1-[(4-hydroxypridin-4-yl) methyl]pyridine-2(1h)-one derivatives, preparation methods and uses thereof |
| 03/20/2013 | EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569305A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569304A1 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569303A1 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569302A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors |
| 03/20/2013 | EP2569301A1 Indazole inhibitors of kinase |
| 03/20/2013 | EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors |
| 03/20/2013 | EP2569299A1 Nitrogen- heterocyclic compounds as phosphodiesterase 10 inhibitors |
| 03/20/2013 | EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 03/20/2013 | EP2569297A1 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569296A1 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/20/2013 | EP2569295A1 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |